Screening through Lead Optimization of High Affinity, Allosteric Cyclin-Dependent Kinase 2 (CDK2) Inhibitors as Male Contraceptives That Reduce Sperm Counts in MiceErik B. Faber, Gunda I. Georg, Rawle Francis et al.|Journal of Medicinal Chemistry|2023Cited by 33
The discovery of high affinity and metabolically stable allosteric cyclin-dependent kinase 2 (CDK2) inhibitors from screening through lead optimizationErik B. Faber, Gunda I. Georg, Nan Wang et al.|ChemRxiv|2022Cited by 1
The discovery of high affinity and metabolically stable allosteric cyclin-dependent kinase 2 (CDK2) inhibitors from screening through lead optimizationErik B. Faber, Gunda I. Georg, Nan Wang et al.|ChemRxiv|2022Cited by 0